Mar 07, 2023 / 02:10PM GMT
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research Analyst
Conference again this year. We have 4 members of management. By the way, I don't have a mic, so I'm just going to talk loudly. Hopefully, you can all hear the questions. But we have 4 members of management here with us, Rob Michael, who is Vice Chairman and President; Scott Reents, who is Executive Vice President and Chief Financial Officer; Jeff Stewart, who's Executive Vice President and Chief Commercial Officer; and Roopal Thakkar, who is Senior Vice President of Development and Regulatory Affairs as well as Chief Medical Officer. So a lot's going on at AbbVie these days, so let's jump right in.
Questions and Answers:
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research AnalystIn no particular order, let's start out with the kind of the future-looking type of question. What new indications and pipeline programs could generate Phase III go, no-go decisions this year that we as investors can look forward to as milestones?
Trustpilot
